These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38700633)

  • 1. Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
    Pemmasani G; Tremaine W; Karagozian R; John S
    Dig Dis Sci; 2024 Jul; 69(7):2691-2698. PubMed ID: 38700633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.
    Stine JG; Shah NL; Argo CK; Pelletier SJ; Caldwell SH; Northup PG
    Liver Transpl; 2015 Aug; 21(8):1016-21. PubMed ID: 25845711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.
    Stine JG; Niccum BA; Zimmet AN; Intagliata N; Caldwell SH; Argo CK; Northup PG
    Clin Transl Gastroenterol; 2018 Mar; 9(3):140. PubMed ID: 29511162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study.
    Axley P; Ahmed Z; Arora S; Haas A; Kuo YF; Kamath PS; Singal AK
    Liver Transpl; 2019 May; 25(5):695-705. PubMed ID: 30861321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography.
    Suresh MG; Gogtay M; Singh Y; Yadukumar L; Mishra AK; Abraham GM
    World J Clin Cases; 2023 Dec; 11(34):8126-8138. PubMed ID: 38130793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients.
    Faccia M; Santopaolo F; Gasbarrini A; Pompili M; Zocco MA; Ponziani FR
    Intern Emerg Med; 2022 Aug; 17(5):1327-1334. PubMed ID: 35076898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.
    Ferrusquía-Acosta J; Bassegoda O; Turco L; Reverter E; Pellone M; Bianchini M; Pérez-Campuzano V; Ripoll E; García-Criado Á; Graupera I; García-Pagán JC; Schepis F; Senzolo M; Hernández-Gea V
    J Hepatol; 2021 Apr; 74(4):811-818. PubMed ID: 33068638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis.
    Rivas G; Hummer-Bair B; Bezinover D; Kadry Z; Stine J
    BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34341018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study.
    Acuna-Villaorduna A; Tran V; Gonzalez-Lugo JD; Azimi-Nekoo E; Billett HH
    Thromb Res; 2019 Feb; 174():137-140. PubMed ID: 30597344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.
    Ambrosino P; Tarantino L; Di Minno G; Paternoster M; Graziano V; Petitto M; Nasto A; Di Minno MN
    Thromb Haemost; 2017 Jan; 117(1):139-148. PubMed ID: 27761574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Andraus W; Lopes LD; Galvão FHF; Song ATW; D'Albuquerque LAC
    Transplant Proc; 2018 Apr; 50(3):758-761. PubMed ID: 29661431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.
    Ali M; Ananthakrishnan AN; McGinley EL; Saeian K
    Dig Dis Sci; 2011 Jul; 56(7):2152-9. PubMed ID: 21279685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH.
    Patel AH; Pathak GN; Chen A; Greenberg P; Mazzaferro N; Patel A; Mallangada N; Minacapelli CD; Catalano K; Suthar H; Rustgi VK
    Ann Hepatol; 2024; 29(4):101510. PubMed ID: 38714224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Abu Rmilah A; Fencl R; Watt K; Krowka M; Wiesner R; Murray D; Nyberg S; Leise M
    Transplantation; 2021 Jul; 105(7):1576-1584. PubMed ID: 32732616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.